1. World Health Organization.Laboratory biosafety guidance related to coronavirus disease 2019 (COVID‐19) Interim guidance. February 12 2020.https://www.who.int/docs/default‐source/coronaviruse/laboratory‐biosafety‐novel‐coronavirus‐version‐1‐1.pdf?sfvrsn=912a9847_2. Accessed March 15 2020.
2. Centers for Disease Control and Prevention Interim guidance for healthcare facilities: preparing for community transmission of COVID‐19 in the United States.https://www.cdc.gov/coronavirus/2019‐ncov/healthcare‐facilities/guidance‐hcf.html. Accessed March 15 2020.
3. Centers for Disease Control and Prevention Laboratory biosafety guidelines for handling and processing specimens associated with SARS‐CoV.https://www.cdc.gov/sars/guidance/f‐lab/app5.html. Accessed March 15 2020.
4. The COVID-19 pandemic: implications for the cytology laboratory
5. International perspectives: Impact of the COVID‐19 pandemic on cytology